TSXV:CLAS.H - Post by User
Comment by
MyKnighton Dec 20, 2019 8:58am
36 Views
Post# 30476019
RE:RE:They unfortunately didn’t manage finances and ran out
RE:RE:They unfortunately didn’t manage finances and ran out And my guess is that portugual are using it in Q1 of 2020....
Money coming in before FDA 3 even starts, europe will use Kaly product pretty soon.... Way before FDA process is done.... They unfortunately didn’t manage finances and ran out
Of money like lot of startups. Unfortunately their patented product could help lot of patients who get bone marrow transplant
to do phase 3 wouldn’t cost lot of money for big pharma and if positive would be good investment e
dither goes bankrupt OR they get backers to do phase3. That’s the risk